CD70: An Emerging Anticancer Target in Renal Cell Carcinoma …
Established
16
Citations43
Refs2024
Year
Search Works
Work Details
- DOI 10.1146/annurev-med-070623-045906
- PMID https://pubmed.ncbi.nlm.nih.gov/39570653
- OpenAlex ID W4404573127
- Type Review
- Language EN
- Published 21 Nov 2024
- Volume 76 (1)
- Pages 257–266
- Source Annual Review of Medicine
- Publisher Annual Reviews
- FWCI 1.20
- Countries 2
- Institutions 3
- Added 21 Nov 2024
- Updated 14 Oct 2026
External Links
MENU
0
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond
Review 2024 EN Hybrid
CD70 is an emerging target for anticancer therapies. It is an ideal antigen target given its limited expression in normal physiologic tissues and propensity to be aberrantly expressed in a variety of malignancies, thus limiting off-target toxicities. It is also heavily involved in immune homeostasis, and disruption of this pathway can help overcome tumor-related immune cell exhaustion. Recent phas…
16
Citations
43
References
3
Authors
1.20
FWCI
Citations by Year
Last 2 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Peter D. Zang | City Of Hope National Medical … (US) City of Hope (US) | |
| 2 | Arkhjamil Angeles | BC Cancer Agency (CA) | |
| 3 | Sumanta Kumar Pal | City Of Hope National Medical … (US) City of Hope (US) |
Related Works
10Data: OpenAlex